Immunotherapy for prostate cancer
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11934-006-0027-8.pdf
Reference62 articles.
1. Wang X, Yu J, Sreekumar A, et al.: Autoantibody signatures in prostate cancer. N Engl J Med 2005, 53:1224–1235. This manuscript demonstrates that prostate cancer does spontaneously generate an immune response that can be detected in the form of antibodies. The presence of these autoantibodies may be used one day as a diagnostic test.
2. Van Parijs L, Abbas AK: Homeostasis and self-tolerance in the immune system: turning lymphocytes off. Science 1998, 280:243–248.
3. Fong L, Engleman EG: Dendritic Cells in cancer immunotherapy. Annu Rev Immunol 2000, 18:245–273.
4. Hudson MA, Bahnson RR, Catalona WJ: Clinical use of prostate-specific antigen in patients with prostate cancer. J Urol 1989, 142:1011–1017.
5. Plowman PN, Perry LA, Chard T: Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer. Br J Urol 1987, 59:255–257.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel therapeutic approaches for the treatment of castration-resistant prostate cancer;The Journal of Steroid Biochemistry and Molecular Biology;2013-11
2. Immuntherapie beim metastasierten Prostatakarzinom – brauchen wir diese wirklich?;Der Urologe;2012-01
3. Immunotherapy for Prostate Cancer: Biology and Therapeutic Approaches;Journal of Clinical Oncology;2011-09-20
4. CD4 T-Cell-mediated immune response to prostatic proteins in HLA-DRB1*1503 transgenic mice and identification of a novel HLA-DRB1*1503-restricted T-cell epitope from human prostatic acid phosphatase;The Prostate;2010-09-30
5. Antibodies against the cancer-testis antigen CTSP-1 are frequently found in prostate cancer patients and are an independent prognostic factor for biochemical-recurrence;International Journal of Cancer;2008-01-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3